活血祛瘀中药加诺氯昔康对创伤骨折后高凝状态的影响
摘要点击次数: 2954   全文下载次数: 1841       
作者Author单位AddressE-Mail
吴征杰 WU Zheng-jie 佛山市中医院 广东佛山528000 Foshan Hospital of TCM,Guangdong Foshan,528000,China  
区锦燕 OU Jin-yan 佛山市中医院 广东佛山528000 Foshan Hospital of TCM,Guangdong Foshan,528000,China  
廖荣宗 LIAO Rong-zong 佛山市中医院 广东佛山528000 Foshan Hospital of TCM,Guangdong Foshan,528000,China  
罗富荣 LUO Fu-rong 佛山市中医院 广东佛山528000 Foshan Hospital of TCM,Guangdong Foshan,528000,China  
周曙 ZHOU Shu 佛山市中医院 广东佛山528000 Foshan Hospital of TCM,Guangdong Foshan,528000,China  
期刊信息:《中国骨伤》2005年,第18卷,第5期,第257-269页
DOI:doi:10.3969/j.issn.1003-0034.yyyy.nn.zzz
基金项目:广东省中医药管理局课题(编号:103144)
中文摘要:

目的:研究探讨活血祛瘀中药加非甾体类消炎止痛药诺氯昔康对创伤骨折后高凝状态干预性治疗的有效性及安全性。

方法:选择创伤股骨多段闭合骨折后当天入院,年龄18~45岁、ASAⅠ级的患者60例。随机分为3组,各20例。对照组(Ⅰ组),入院后不用任何对凝血功能有影响的药物。中药组(Ⅱ组),入院第2天即给予活血祛瘀中药。中西药组(Ⅲ组),在Ⅱ组基础上加用诺氯昔康。Ⅱ、Ⅲ组用药从入院第2天至第6天。3组患者均在入院第2天、第7天(术日清晨)抽血测定:D D二聚体(D Di)、血小板计数(PLC)、血小板聚集率(PAgR)、凝血弹性描记仪(TEG)的相关指标:R、K、α角、MA。并与健康成年人上述指标进行比较。

结果:3组患者骨折后第2天D Di、α角、MA与健康成年人比较P<0.05。3组患者随骨折时间延长至第7天D Di、PAgR、α角、MA均比第1天增大,Ⅰ组增大更明显,PAgR增大的数值(25.49±18.94)与Ⅱ组(9.69±24.89)、Ⅲ组(9.70±14.80)比较有差异(P<0.05)。D Di增加Ⅰ组(277.75±860.25)与Ⅲ组(-189.00±413.68)比较有差异(P<0.05)。α角度增大Ⅰ组(6.17±7.25)与Ⅲ组(1.73±3.78)比较有差异(P<0.05)。

结论:患者创伤骨折后凝血功能24h内增强,随时间延长至第7天呈高凝状态,中药、中西结合用药可降低血小板聚集率,有助于降低创伤骨折后深静。
【关键词】股骨骨折  高凝固性  活血祛瘀药  诺氯昔康
 
Effects of promoting blood flow and removing stasis(活血祛瘀)of traditional Chinese medicine combined with Lornoxcam (NSAIDs) on hypercoagulability state after traumatic femoral fracture
ABSTRACT  

Objective: To investigate the effectiveness and safety of promoting blood flow and removing stasis of traditional Chinese medicine and Lornoxcam(NSAIDs) on hypercoagulability after traumatic femoral fracture.

Methods:Sixty patients of femoral fracture were selected with the age 18~45 years and ASA Ⅰ.They were randomly and evenly divided into three groups.In control group (Group Ⅰ) no drugs that affect coagulation were given after their hospitalization.In Chinese medicine group(Group Ⅱ) the patients were given Chinese medicine of promoting blood and removing stasis after their hospitalization until the day before operation(2nd~6th day).In combined Western-Chinese medicine group(Group Ⅲ),the patients were given Lornoxcam and the same Chinese medicine as group Ⅱ from hospitalization to the day before operation.Blood samples were drawn from all patients on the 2nd and 7th day to measure the following indices:D-dimer,platelet count (PLC),platelet agglutination rate(PAgR) and thromboelastograph(TEG).The results were compared with healthy adult volunteers.

Results:The 2nd day indices of D-dimer,alpha angle,maximum amplitude(MA) of all patients were significantly different from those of healthy volunteers (P<0.05).The D-dimer,PAgR,alpha angle and MA in the 7th day were significantly increased compared with the 2nd day.The most significant changes were observed in group Ⅰ.Its PAgR(25.49±18.94)were significantly higher than that of group Ⅱ(9.96±24.89,P<0.05) and group Ⅲ(9.70±14.80,P<0.05).D-dimer and alpha angle in group Ⅰ were dramatically increased compared with group Ⅲ(277.75±860.25 vs-189.00±413.68,6.17±7.52 vs 1.73±3.78 respectively,P<0.05).

Conclusion:The state of hypercoagulability were observed in patients who were traumatic femoral fracture.Traditional Chinese medicine,especially combined with Western medicine,will decrease the platelet agglutination rate and coagulability,which will be helpful to decrease the probability of deep vein thrombosis after traumatic femoral fracture.
 
引用本文,请按以下格式著录参考文献:
中文格式:吴征杰,区锦燕,廖荣宗,罗富荣,周曙.活血祛瘀中药加诺氯昔康对创伤骨折后高凝状态的影响[J].中国骨伤,2005,18(5):257~269
英文格式:WU Zheng-jie,OU Jin-yan,LIAO Rong-zong,LUO Fu-rong,ZHOU Shu.Effects of promoting blood flow and removing stasis(活血祛瘀)of traditional Chinese medicine combined with Lornoxcam (NSAIDs) on hypercoagulability state after traumatic femoral fracture[J].zhongguo gu shang / China J Orthop Trauma ,2005,18(5):257~269
阅读全文  下载  查看/发表评论  下载PDF阅读器
关闭




版权所有:《中国骨伤》杂志社京ICP备12048066号-2  版权声明
地址:北京市东直门内南小街甲16号,100700
电话:010-64089487 传真:010-64089792 Email:zggszz@sina.com

京公网安备 11010102004237号